Product Wiki · Recalls · U.S. FDA — Device Enforcement

Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC… — recall Z-1065-2016

U.S. FDA — Device Enforcement · United States · 2016-01-18 · Class II

As described by U.S. FDA — Device Enforcement: Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC, Garbin, Garbin Plus Trilogy 100, Trilogy 200, Garbin, Garbin plus provides continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1065-2016
Date of alert
2016-01-18
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Philips Respironics
Product category
device
Product type
Devices
Recall status
Terminated — the recall action is complete and the FDA has closed it
Initiated by
Voluntary: Firm initiated
Distribution
Nationwide Distribution including Puerto Rico and Internationally to the US Virgin Islands.
Reported risk: Software Issue
Primary source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?start_search=1&

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.